LEADER 02266nam  2200649Ia 450 
001 9910781867603321
005 20200520144314.0
010   $a1-61122-122-6
035   $a(CKB)2550000000060414
035   $a(EBL)3018895
035   $a(SSID)ssj0000569604
035   $a(PQKBManifestationID)12204072
035   $a(PQKBTitleCode)TC0000569604
035   $a(PQKBWorkID)10587017
035   $a(PQKB)11091975
035   $a(MiAaPQ)EBC3018895
035   $a(Au-PeEL)EBL3018895
035   $a(CaPaEBR)ebr10661834
035   $a(OCoLC)923659442
035   $a(EXLCZ)992550000000060414
100   $a20100823d2011      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aNanotechnology considerations for the EPA and FDA$b[electronic resource] /$fScott J. Castiglione, editor
210   $aHauppauge, N.Y. $cNova Science Publishers$dc2011
215   $a1 online resource (175 p.)
225 1 $aNanotechnology science and technology.
300   $aDescription based upon print version of record.
311   $a1-61761-817-9 
320   $aIncludes bibliographical references and index.
410  0$aNanotechnology science and technology series.
606   $aNanoparticles$xEnvironmental aspects
606   $aNanoparticles$xToxicology
606   $aNanostructured materials$xEnvironmental aspects
606   $aNanostructured materials$xHealth aspects
606   $aNanotechnology$xEnvironmental aspects
606   $aNanotechnology$xHealth aspects
606   $aNanotechnology$xGovernment policy$zUnited States
615  0$aNanoparticles$xEnvironmental aspects.
615  0$aNanoparticles$xToxicology.
615  0$aNanostructured materials$xEnvironmental aspects.
615  0$aNanostructured materials$xHealth aspects.
615  0$aNanotechnology$xEnvironmental aspects.
615  0$aNanotechnology$xHealth aspects.
615  0$aNanotechnology$xGovernment policy
676   $a363.17
701   $aCastiglione$b Scott J$01554373
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910781867603321
996   $aNanotechnology considerations for the EPA and FDA$93815586
997   $aUNINA